Equity Overview
Price & Market Data
Price: $0.021
Daily Change: -$0.089 / 423.8%
Daily Range: $0.021 - $0.021
Market Cap: $424,501
Daily Volume: 144
Performance Metrics
1 Week: -80.91%
1 Month: %
3 Months: -77.32%
6 Months: -84.38%
1 Year: -93.00%
YTD: -77.32%
Details
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. Its lead product candidate is ImMucin, a MUC1 SP-based vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. The company is headquartered in Toronto, Canada.